Emami Limited announced its financial results for the quarter ended September 30, 2024 (Q2 FY 2025).
In the quarter, the company’s revenue from operations reached ₹891 crore, showing a 3% year-over-year growth. This growth was supported by solid performance across both domestic and international markets.
Emami’s domestic business recorded a 2.6% increase, while the international business grew by 6%. Excluding Bangladesh, international sales saw a 12% rise, driven by robust demand for flagship brands such as Navratna, Dermicool, and the company’s healthcare and pain management products.
Innovation remains a key driver for Emami, with 11 new product launches this quarter. Highlights among these innovations include the DermiCool Sweat Reliever Super Active Talc, Ice Cool Shower Gel, De-Tan & Deep Cleansing Face Wash, Style Lock Shampoo, Fresh Impact Body Wash, and Odour Control Shower Gel.
Under its brand ‘HE’, the company introduced two new EDT perfumes. In healthcare, Emami continued to expand its Zanducare portal with products like Zandu Daily Health Super Greens, Zandu Dirghayuprash, and Zandu Hair Growth Serum. Emami also relaunched its BoroPlus Soft light moisturising cream with an updated look, aiming to appeal to a broader consumer base.
The company’s international segment demonstrated resilience amid global uncertainties, delivering a 6% increase in revenue, both in constant currency and INR terms, largely thanks to the strong performance in the Middle East and North Africa (MENA) region. Notably, sales growth excluding Bangladesh was an impressive 12%, highlighting the company’s adaptability in challenging markets.
Emami reported an EBITDA of ₹250 crore for Q2 FY 2025, marking a 7% increase over the same period last year. This also led to a 110-basis-point improvement in EBITDA margins, reaching 28.1%. Additionally, profit after tax (PAT) rose to ₹213 crore, a significant 19% year-over-year growth.
The company declared an interim dividend of 400%, equating to ₹4 per share for FY 2025.
Furthermore, Emami increased its stake in Helios Lifestyle, known for “The Man Company,” from 50.4% to 98.3%, reinforcing its commitment to expanding in the personal care segment. With strategic investments, a diversified product portfolio, and strong international growth, Emami continues to show resilience and adaptability in a competitive market.
Vice Chairman and Whole-Time Director at Emami, Mr Mohan Goenka, said, “The Q3 relaunch of Fair and Handsome and focused efforts on Kesh King strengthens our confidence in driving H2 growth. With a favourable winter forecast, we expect a strong performance from our winter portfolio.”
On November 8, 2024, Emami share price opened at ₹688.00, touching the day’s low at ₹664.55, as of 9:57 AM on the NSE.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates